A multicenter randomized double-blind trial comparing rosiglitazone to placebo for the prevention of atherosclerosis progression after coronary bypass surgery in diabetic patients
Latest Information Update: 17 Jul 2023
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms VICTORY
- 01 Sep 2009 Design and trial rationale published in the Canadian Journal of Cardiology.
- 29 Apr 2008 Results presented at ACC 2008
- 26 Nov 2005 New trial record.